Tower Pharmacy and CompoundingSeptember 19, 2019

FDA 483 - Tower Pharmacy and Compounding - September 19, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Tower Pharmacy and Compounding

Record Details

Tower Pharmacy and Compounding in Mission Viejo, CA, received an FDA Form 483 for significant deficiencies observed during an inspection. The firm was cited for inadequate containment, segregation, and cleaning practices for highly potent drugs, leading to potential cross-contamination. Additionally, the pharmacy routinely used non-pharmaceutical grade components in the formulation of various compounded drug products.

Company: Tower Pharmacy and Compounding
Inspection Date: September 19, 2019
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations IV
Person: Christopher R. Czajka (Consumer Safety Officer (Inspector))

Open in Dashboard

ID · 9cd24748-a1a1-4149-a8a4-cd23d64c75ab